|
AU2013273711A1
|
|
Method of making small liposomes
|
|
AU2012268892A1
|
|
Method of Treating Patients with a Mucinous Glycoprotein (MUC-1) Vaccine
|
|
AU2012222188A1
|
|
MUC1 based glycolipopeptide vaccine with adjuvant
|
|
EP2658852A2
|
|
Compositions and methods of using crystalline forms of wortmannin analogs
|
|
WO2012058325A1
|
|
Compounds and methods useful for treatment of diseases mediated by hif-1
|
|
WO2011153488A1
|
|
Combination cancer therapies with wortmannin analogs
|
|
BRPI1015940A2
|
|
pi-3 kinase inhibitor methods and compositions for treating fibrosis
|
|
SG172257A1
|
|
Method of making small liposomes
|
|
TW201615208A
|
|
Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
|
|
TW200538147A
|
|
Mucinous glycoprotein (muc-1) vaccine
|
|
AU2003224878A1
|
|
Synthetic glyco-lipo-peptides as vaccines
|
|
EP1852126A2
|
|
Vaccine for modulating between T1 and T2 immune responses
|
